Wojciech Jankowski

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Venous Thromboembolism

Direct Oral Anticoagulants

Dna Methylation

Capillary Electrophoresis

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Wojciech Jankowski, Stepan S Surov, Nancy E Hernandez, Atul Rawal, Marcos Battistel, Darόn I Freedberg, Mikhail V Ovanesov, Zuben E Sauna
Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding. Nature communications 15 (1) (2024)
Wojciech Jankowski, Stepan S Surov, Nancy E Hernandez, Atul Rawal, Marcos Battistel, Darόn I Freedberg, Mikhail V Ovanesov, Zuben E Sauna
Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding. Nature communications 15 (1) (2024)
Wojciech Jankowski, Stepan S Surov, Nancy E Hernandez, Atul Rawal, Marcos Battistel, Darόn I Freedberg, Mikhail V Ovanesov, Zuben E Sauna
Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding. Nature communications 15 (1) (2024)
Wojciech Jankowski, Stepan S Surov, Nancy E Hernandez, Atul Rawal, Marcos Battistel, Darόn I Freedberg, Mikhail V Ovanesov, Zuben E Sauna
Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding. Nature communications 15 (1) (2024)
Wojciech Jankowski, Joseph R McGill, H A Daniel Lagassé, Stepan Surov, Gary Bembridge, Campbell Bunce, Edward Cloake, Mark H Fogg, Katarzyna I Jankowska, Abdul Khan, Joseph Marcotrigiano, Mikhail V Ovanesov, Zuben E Sauna
Mitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogue. Blood advances 3 (17) (2020)